We hope you enjoyed the BIO-EUROPE SPRING® 2022 virtual event, where our Subject Matter Experts provided key insights on the following hot topic:
Next generation biologics – manufacturing and supply strategies to accelerate time to market
Recent advances in technology have seen the development of many new types of biologics that have been particularly effective at targeting specific diseases. Increased complexities may lead to technical challenges resulting in longer CMC development timelines, a delay to clinical trials, and delayed commercial launches.
Should we have missed out on connecting at BIO-EUROPE SPRING® 2022, reach out to us to find out more about how we help pharma and new and emerging biotech companies turn pharmaceutical possibilities into realities and get to market faster.